Using the DGIdb database, four key NLRP3 inflammasome-related genes (APP, HSP90AB1, NFKB and TLR4) were further selected as potential druggable targets for Crohn’s disease treatment (Figure 11B). The gene discussed is APP; the disease is Crohn disease.